ADC Therapeutics to Participate in the Jefferies Healthcare Conference
June 01, 2023 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
Tessa Therapeutics’ Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano
May 30, 2023 06:12 ET
|
Tessa Therapeutics Ltd
SINGAPORE, May 30, 2023 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and...
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
April 12, 2023 07:30 ET
|
Adaptive Biotechnologies
SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market to Grow by $1.65 Billion During 2023-2027
March 15, 2023 08:13 ET
|
Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global BCL-2 (B-cell lymphoma 2) Inhibitors Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The BCL-2 (B-cell Lymphoma...
Global Hemato Oncology Testing Market Report 2022 to 2027: Drug Diagnostics Co-Development Presents Opportunities
December 12, 2022 08:14 ET
|
Research and Markets
Dublin, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma...
Global Leukapheresis Market Report 2022: Increased Demand for Leukopaks in Clinical Research Driving Growth
October 25, 2022 06:28 ET
|
Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma),...
Blood Irradiation Market Worth $104.37 million, Globally, by 2028 Growing at 7.0% CAGR Says, The Insight Partners
July 27, 2022 09:30 ET
|
The Insight Partners
New York, July 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Blood Irradiation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product,...
Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
June 30, 2022 14:24 ET
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; June 30, 2022 – Genmab A/S (Nasdaq: GMAB) today announced its intent to submit a biologics license application (BLA) to the U.S. Food and Drug...
Ovarian Cancer Market to reach a market size of USD 19.92 Billion by 2030 growing at a CAGR of 23.8%: Straits Research
May 30, 2022 12:50 ET
|
Straits Research
New York, United States, May 30, 2022 (GLOBE NEWSWIRE) -- Ovarian cancer drugs are sold to treat ovarian cancer in the Ovarian Cancer Market. The leading cause of ovarian cancer is abnormal cell...
Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Size to Expand Significantly USD 4476.99 Million By 2030
May 11, 2022 16:00 ET
|
Fior Markets
Newark, NJ, May 11, 2022 (GLOBE NEWSWIRE) -- As per the report published by MRInsights.biz, the global Bruton tyrosine kinase (BTK) inhibitors market is expected to grow from USD 2,695.35 million in...